Viewing Study NCT04866056


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-02 @ 4:47 PM
Study NCT ID: NCT04866056
Status: TERMINATED
Last Update Posted: 2022-12-01
First Post: 2021-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
None Myeloproliferative Neoplasms View
None Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View
None MF View
None MPN View